Komipharm International Co. Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.013x

Komipharm International Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Komipharm International Co. Ltd (041960) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩946.94 Million ≈ $641.73K USD) by net assets (₩72.06 Billion ≈ $48.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Komipharm International Co. Ltd (2013–2025)

Cash flow conversion efficiency of Komipharm International Co. Ltd from 2013 to 2025. This chart illustrates how Komipharm International Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Komipharm International Co. Ltd for real-time trading data and today's change.

Komipharm International Co. Ltd Cash Flow Conversion Ratio Explained

Komipharm International Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Komipharm International Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Komipharm International Co. Ltd ranked by their cash flow conversion efficiency. Also see how much is Komipharm International Co. Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Dimerco Express TWO:5609	-0.024x
Integra Resources Corp V:ITR	0.262x
Alpha Hpa Ltd AU:A4N	-0.030x
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd SHE:300313	-0.906x
Alantra Partners S.A. MC:ALNT	0.020x
Kamada TA:KMDA	0.039x
Shandong Minhe Animal Husbandry Co Ltd SHE:002234	0.026x
Sunfly Intelligent Technology Co Ltd SHE:300423	-0.016x

Annual Cash Flow Conversion Efficiency for Komipharm International Co. Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Komipharm International Co. Ltd from 2013 to 2025. Review cash generation quality of Komipharm International Co. Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩72.06 Billion ≈ $48.83 Million	₩-621.80 Million ≈ $-421.39K	-0.009x	-106.39%
2024-12-31	₩65.54 Billion ≈ $44.41 Million	₩8.85 Billion ≈ $6.00 Million	0.135x	+389.35%
2023-12-31	₩60.02 Billion ≈ $40.67 Million	₩-2.80 Billion ≈ $-1.90 Million	-0.047x	-56.46%
2022-12-31	₩60.63 Billion ≈ $41.09 Million	₩-1.81 Billion ≈ $-1.23 Million	-0.030x	-57.78%
2021-12-31	₩66.46 Billion ≈ $45.04 Million	₩-1.26 Billion ≈ $-851.13K	-0.019x	-5819.79%
2020-12-31	₩76.28 Billion ≈ $51.69 Million	₩25.20 Million ≈ $17.08K	0.000x	-97.45%
2019-12-31	₩73.28 Billion ≈ $49.66 Million	₩950.79 Million ≈ $644.34K	0.013x	+160.06%
2018-12-31	₩93.39 Billion ≈ $63.29 Million	₩-2.02 Billion ≈ $-1.37 Million	-0.022x	-1028.56%
2017-12-31	₩101.27 Billion ≈ $68.63 Million	₩235.64 Million ≈ $159.69K	0.002x	-82.06%
2016-12-31	₩93.20 Billion ≈ $63.16 Million	₩1.21 Billion ≈ $819.00K	0.013x	+133.70%
2015-12-31	₩76.13 Billion ≈ $51.59 Million	₩-2.93 Billion ≈ $-1.98 Million	-0.038x	+19.33%
2014-12-31	₩53.16 Billion ≈ $36.02 Million	₩-2.54 Billion ≈ $-1.72 Million	-0.048x	-154.21%
2013-12-31	₩44.72 Billion ≈ $30.31 Million	₩3.93 Billion ≈ $2.67 Million	0.088x	--

About Komipharm International Co. Ltd

KQ:041960 Korea Pharmaceuticals

Market Cap

$343.99 Million

₩507.59 Billion KRW

Market Cap Rank

#13842 Global

#411 in Korea

Share Price

₩8780.00

Change (1 day)

-1.68%

52-Week Range

₩5890.00 - ₩11550.00

All Time High

₩43026.96